Back
Iterum Therapeutics PLC Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
ITRM
Iterum Therapeutics PLC
Last Price:
$1.76
Seasonality Move:
4.65%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.Iterum Therapeutics PLC Stock Forecast
-
Is Iterum Therapeutics PLC Stock Undervalued?The current Iterum Therapeutics PLC [ITRM] share price is $1.77. The Score for ITRM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
ITRM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Iterum Therapeutics PLC Stock Go Up Next Year?
Data Unavailable
Iterum Therapeutics PLC Stock Rating
Data Unavailable
Iterum Therapeutics PLC Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Ireland
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
iterumtx.com
52-Week Data
52-Week High:
3.02
52-Week Low:
0.81
Prediction Charts
Market Cap:
29.3M
Price in USD:
1.77
Volume:
665.9K
Beta:
2.33
Technical Analysis
SMA50:
1.62
SMA100:
1.37
SMA200:
1.40
52-Wk Change:
5.99%
Stock Predictions
-
Is Iterum Therapeutics PLC stock public?Yes, Iterum Therapeutics PLC is a publicly traded company.
-
What is the Iterum Therapeutics PLC stock quote today?The Iterum Therapeutics PLC stock price is 1.77 USD today.
-
How to buy Iterum Therapeutics PLC stock online?You can buy Iterum Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-3 | 2.50 | 2.24 | 2.52 | 2.20 |
| Dec-4 | 2.30 | 2.39 | 2.42 | 2.20 |
| Dec-5 | 2.45 | 2.84 | 2.95 | 2.40 |
| Dec-6 | 2.94 | 2.70 | 2.95 | 2.55 |
| Dec-9 | 2.71 | 2.91 | 3.02 | 2.70 |
| Dec-10 | 2.39 | 2.30 | 2.62 | 2.25 |
| Dec-11 | 2.12 | 1.98 | 2.27 | 1.85 |
| Dec-12 | 2.00 | 1.98 | 2.18 | 1.95 |
| Dec-13 | 1.99 | 1.80 | 2.05 | 1.78 |
| Dec-16 | 1.79 | 1.87 | 1.92 | 1.79 |
| Dec-17 | 1.86 | 1.83 | 1.95 | 1.80 |
| Dec-18 | 1.83 | 1.67 | 1.86 | 1.63 |
| Dec-19 | 1.70 | 1.75 | 1.77 | 1.69 |
| Dec-20 | 1.75 | 1.77 | 1.81 | 1.75 |
Iterum Therapeutics PLC Earnings
Data Unavailable
Iterum Therapeutics PLC Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.53 per share, and an increase next year of $0.21 per share.
* Iterum Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.